AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimzy M 2mg/500mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Zylig Lifesciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimzy M 2mg/500mg Tablet ER

Diabex Duo 2mg/500mg Extended-Release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle choices significantly influence diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms—sweating, dizziness, headache, tremors—and appropriate countermeasures. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional side effects may include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is a possible consequence. This medication is contraindicated for type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Consult your doctor prior to use during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, along with potential blood tests to assess blood cell counts and liver function.

Primary Ingredients of Glimzy M 2mg/500mg Tablet ER

No information provided. A rewrite is impossible.

Uses of Glimzy M 2mg/500mg Tablet ER

Managing type 2 diabetes

Major Benefits of Glimzy M 2mg/500mg Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the Glimzy M 2mg/500mg Extended-Release tablet whole; avoid chewing, crushing, or fracturing. Consume with food.

Common Side effects of Glimzy M 2mg/500mg Tablet ER:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimzy M 2mg/500mg Tablet ER:

Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Consume Glimzy M 2mg/500mg Extended-Release tablets with food.

How Glimzy M 2mg/500mg Tablet ER works:

Glimzy M ER tablets (2mg/500mg) combine the anti-diabetic agents glimepiride and metformin. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimzy M 2mg/500mg Extended-Release Tablets with alcohol is hazardous.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Glimzy M 2mg/500mg tablet might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Extended-release Glimzy M 2mg/500mg tablets are contraindicated during lactation. Evidence indicates potential infant toxicity from this medication.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Glimzy M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates the use of Glimzy M 2mg/500mg Extended-Release tablets. Physician consultation is essential. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimzy M 2mg/500mg Extended-Release tablets cautiously, potentially requiring dosage modification. A physician's consultation is recommended. For those with mild to moderate liver disease, initiation should be at a low dose; it's contraindicated in cases of severe hepatic dysfunction.

What if you forget to take Glimzy M 2mg/500mg Tablet ER :

Should you forget to take your Glimzy M 2mg/500mg Extended-Release tablet, administer it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Glimzy M 2mg/500mg Tablet ER

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Glimzy M 2mg/500mg Tablet ER

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication. Keep out of reach of children, pets, and others.
Glimzy M 2mg/500mg Tablet ER can cause lactic acidosis, a serious medical emergency resulting from excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Glimzy M 2mg/500mg Tablet ER and seek immediate medical attention.
Glimzy M 2mg/500mg Extended-Release tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood sugar control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Glimzy M 2mg/500mg Tablet ER may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged use of Glimzy M 2mg/500mg Tablet ER can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glimzy M 2mg/500mg Tablet ER can indeed cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, and anxiety or shakiness. This risk increases with missed or delayed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimzy M 2mg/500mg ER tablets with alcohol is unsafe. Alcohol can worsen the drug's blood sugar-lowering effects, potentially causing hypoglycemia and increasing the risk of lactic acidosis.
Glimzy M 2mg/500mg Tablet...
82
MRP 95
13% off